Endotoxin
causes acute lung injury resembling acute respiratory distress syndrome. Elastase, as well as reactive oxygen species released from activated neutrophils, are thought to play pivotal roles in the pathogenesis of this lung injury. This study investigated whether ONO-5046, a specific elastase inhibitor, can attenuate acute lung injury induced by endotoxin in rabbits. Thirty-two male anesthetized rabbits were randomly assigned to receive one of four treatments (n = 8 for each group): infusion of saline without ONO-5046 treatment (Group S-S), infusion of saline with ONO-5046 (Group S-O), infusion of Esckevickia coli endotoxin (100 pg/kg over 60 min) without ONO-5046 (Group E-S), and infusion of endotoxin with ONO-5046 (Group E-O). Fifteen minutes before the infusion of endotoxin (Groups E-O and E-S) or saline (Groups S-S and S-O), the animals received a bolus injection of ONO-5046 (10 mg/kg) followed by continuous infusion (10 mg * kg-' * h-': Groups S-O and E-O) or saline (Groups S-S and E-S). The lungs of the rabbits were ventilated with 40% oxygen. Hemodynamics, peripheral leukocyte and platelet counts, and Pao, were recorded during the ventilation period (6 h). Lung mechanics, cell fraction of the bronchoalveolar lavage fluid (BALF), activated complement, cytokines, and arachidonic acid metabolite concentrations in the BALF were measured at 6 h. The wet-to dry (W/D)-weight ratio of the lung and albumin concentrations in BALF were analyzed as indices of pulmonary edema. Endotoxin decreased lung compliance and Pao,, and increased the W/D weight ratio, neutrophil counts, and albumin concentration in the BALF. Concentrations of activated complement C5a, interleukin-6, interleukin-8, and thromboxane B, in the BALF were increased by the infusion of endotoxin.
ONO-5046 treatment attenuated these changes. Endotoxin caused extensive morphologic lung damage, which was lessened by ONO-5046. In conclusion, intravenous ONO-5046 pretreatment attenuated endotoxin-induced lung injury in rabbits. This beneficial effect of ONO-5046 may be due, in part, to a reduction in the levels of mediators that activate neutrophils, in addition to the direct inhibitory effect on elastase.
( 1997;84:1097-103 the same lot; Difco, Detroit, MI) 100 /.&kg over 60 min, whereas Groups S-S (control group) and S-O received an infusion of saline instead of endotoxin. In Groups E-O and S-O, ONO-5046 (Ono Pharmaceutical Co., Osaka, Japan) 10 mg/kg was intravenously (IV) injected 15 min before the endotoxin infusion and was continuously infused at a rate of 10 mg . kg-l * h-l until the end of the experiment.
The drug was dissolved in normal saline to a concentration of 10 mg/mL immediately before use. Rabbits in Grou.ps E-S and S-S received an injection and infusion of saline (1 mL/kg and 1 mL * kg-* * h-l, respectively) instead of ONO-5046.
The animals were anesthetized with ketamine 20 mg/kg IV and tracheally intubated with a 3.5-mm endotracheal tube through a tracheotomy. An IV catheter was inserted into an ear vein for the administration of fluid and drugs. Via a femoral cutdown, a catheter was placed in the distal aorta to monitor arterial pressure and to obtain samples for blood gas analysis. Pulmonary arterial pressure (PAP) was continuously monitored with a flow-directed pulmonary artery catheter inserted through the right internal jugular vein. Central venous pressure was also monitored via a catheter inserted through the femoral vein. The animals were paralyzed with repeated doses of IV pancronium and mechanically ventilated using an infant ventilator with 40% oxygen. Tidal volume was set to 10 mL/kg measured by pneumotachograph. Respiratory rate was controlled to prbduce an initial Pace, of 35-40 mm Hg. The animals were placed on a heating pad under a radiant heat lamp to keep the intraoral temperature between 37.8 and 40.2"C. Lactated Ringer's solution was administered IV at a rate of 8 mL * kg-' * h-l. Hemodynamic data and blood samples for arterial gas analysis were obtained once every hour. Anesthesia was maintained with a continuous infusion of ketamine at a rate of 10 mg . kg-l * h-l. All rabbits were killed 6 h after the start of endotoxin treatment by an injection of thiamylal.
Assessment of Acute Lung Injury
Analysis of Blood Samples and Measurement of Lung Mechanics. Arterial blood specimens were obtained for analysis of Pao2, Pace,, and pH, and the number of leukocytes and platelets was measured with a Coulter counter. The number of peripheral leukocytes was assessed by the Biirker-Tiirk method (8). Immediately after the start of mechanical ventilation and before the rabbits were killed, lung mechanics were measured by the passive expiratory flow-volume technique (9). The airflow was measured with a Flemish 00 pneumotachograph and a differential pressure transducer. Airway pressure was measured at the proximal end of the pneumotachometer with a semiconductor pressure transducer. The volume was determined for each breath by digital integration of airflow using a respiration monitor (Aivision, Tokyo, Japan) and a personal computer. Compliance and resistance of the total respiratory system were then calculated by personal computer.
Preparation of Bronchoalveolar Lavage Fluid and Measurements. After the rabbits were killed, the heart and lungs were removed en bloc. Through the right mainstem bronchus, 35 mL saline with EDTA 2 Na at 4°C was slowly infused and withdrawn. This procedure was repeated five times. Indomethacin was added to the bronchoalveolar lavage fluid (BALF) to inhibit further metabolism of arachidonic acid to prostaglandins during analysis. The BALF was analyzed for cell count and differential. A cytocentrifuged preparation (Cytospin 2; Shandon Inc., Pittsburgh, PA) of the BALF was stained with Wright-Giemsa for cell differential. The cells present in the fluid were counted by the Biirker-Tiirk method. The fluid was centrifuged at 2508 at 4°C for 10 min to remove the cells. The cell-free supernatant was divided into several aliquots and stored at -70°C until assay. The following substances in the BALF were then measured. Activated components of complement (C3a and C5a) were quantified by radioimmunoassay (Assay Protocol of BIOTJXAK; Amersham, Buckinghamshire, UK). Albumin concentrations were determined by immunoturbidimetry with the immunoglobulin G fraction of goat antirabbit albumin (Cappel, PA), while concentrations of tumor necrosis factor a! (TNF,), interleukin-6 (IL-6), and interleukin-8 (IL-8) were measured by enzyme immunoassay (Assay Protocol of BIOTRAK, Amersham). The concentrations of thromboxane A, (TxA,) and prostacyclin were quantified by radioimmunoassay (Assay Protocol of BIOTRAK, Amersham) as TxB, and 6-keto prostaglandin F1,, their stable metabolites, respectively. Lung Wet-to Dry-Weight Ratio. The severity of pulmonary edema was assessed by the wet-to dry (W/D&weight ratio of the lung. The left upper lobe was weighed and then dried to a constant weight at 60°C for 24 h in an oven.
Histopathologic Exumination. Immediately after the rabbits were killed, the lower lobe of the left lung was fixed by the instillation of 10% formaldehyde solution through the left lower bronchus at 20 cm H,O. The specimens were embedded in paraffin wax, stained with hematoxylin and eosin, and examined under a light microscope. Lung injury was scored by a blinded observer using a 5-point scale according to combined assessments of alveolar congestion, hemorrhage, infiltration or aggregation of neutrophils in the airspace or vessel wall, and thickness of alveolar wall/hyaline membrane formation: 0 = minimum damage, l+ = mild damage, 2+ = moderate damage, 3+ = severe damage, and 4+ = maximum damage.
Statistical Analysis
The data on lung injury score are given as median (range), whereas the other data are expressed as mean t SEM. Parametric data were analyzed using analysis of variance, and repeated-measures two-way analysis of variance was used to test for significant differences between and within groups. The lung injury scores were analyzed using the Kruskall-Wallis rank test. P < 0.05 was accepted as significant. (Fig. 1) . The arterial and central venous pressure values did not differ among the four groups at any point. The infusion of endotoxin caused an increase in PAP followed by a gradual decrease (Table 1 ). The increase in PAP was attenuated by ONO-5046.
Results
The peripheral leukocyte and platelet counts gradually decreased during and after the infusion of endotoxin (Table  1) . ONO-5046 slightly attenuated these decreases.
Lung Mechanics
Neither compliance nor resistance immediately after mechanical ventilation was different among the four groups (Table 2) . At the end of the experiment, compliance decreased and resistance increased in the 
Analysis of BALF
The recovery percentages of the BALF in the four groups was 79%-86%, with no significant differences among the groups. The number of leukocytes in BALF was significantly more in the endotoxin groups compared with that in the control group. However, ONO-5046 attenuated the increase in leukocyte count in the BALF (Table 3 ). The leukocytes in the control group were mostly macrophages. The percentage of neutrophils (%PMN) in the BALF obtained from Group E-S was as high as 13.1%. ONO-5046 blunted the increase in %PMN (7.3%). Albumin concentrations in the BALF were higher in Group E-S than in Group S-S. ONO-5046 decreased the albumin influx into alveolar spaces. Concentrations of C3a and C5a were higher in Group E-S than in Group S-S (Table 3) . However, the concentration of C5a in the E-O group was comparable to that in the control group. The concentrations of TNF,, IL-6, IL-8, and TxB, in the BALF were increased by endotoxin. ONO-5046 treatment suppressed the release of the cytokines in the lung, although it failed to reduce the TxB, levels. The concentrations of 6-keto-prostaglandin F,, were comparable among the four groups.
Lung W/D-Weight Ratio
The ratio increased in rabbits receiving endotoxin compared with those receiving saline (Fig. 2) . ONO-5046 attenuated the increase in this ratio.
Histopathological Grading
Light microscopic examination showed that endotoxin caused edema, hemorrhage, increased thickness of alveolar wall, and infiltration of inflammatory cells into 
Discussion
We have shown that ONO-5046 attenuates the physiological, biochemical, and histological deterioration in the lung induced by endotoxin. ONO-5046 attenuated the pulmonary edema as shown by the amelioration of the increased W/D-weight ratio and albumin levels in the BALF. The protective effect of ONO-5046 may be due, in part, to protection of the pulmonary endothelium from the elastase released by neutrophils. ONO-5046 attenuated the dramatic reduction of the peripheral neutrophil counts and the increased %PMN in the BALF. This finding indicates that the drug also attenuated the accumulation of neutrophils in the lung. The concentration of IL-8, a potent chemotaxin (lo), in the BALF was lower in Group E-O than in Group E-S. This reduction may contribute to the suppressive effect of ONO-5046 on the accumulation of neutrophils in the lung. In the current study, ONO-5046 blunted the increases of TNF, and IL-6, which are known to correlate with the degree of inflammatory response (11, 12) . ONO-5046 is a highly selective elastase inhibitor, with a 50% inhibiting concentration of 0.036 PM for elastase of rabbits. at a dose of 10 mg * kg-* * h-i significantly attenuated the alveolar hemorrhage induced by phorbol myristate acetate in rabbits. We have no pharmacokinetic data for the drug in rabbits. However, the constant blood level of ONO-5046 given at a dose of 10 mg * kg-* * h-l is reported to be 22 pg/mL in rats and 13 pg/mL in dogs, reached within 1.5 h (13). Although elastase c Figure  3 . Light micrograph (hematoxylm and eosin, X100) of the lung. A, E-S group; B, E-O group. activities were not determined in the present study, ONO-5046 at a dose of 10 mg * kg-' * h-i seems to be sufficient to inhibit neutrophil elastase, on the basis of a study in a leukotriene B4-induced lung injury model (4). Thus, we used a dose of 10 mg * kg-' * h-i of ONO-5046 for continuous infusion.
The neutrophil elastase plays a prominent role in the pathogenesis of ARDS (3,4). Increases in neutrophi1 counts and elastase levels in the BALF have been documented in patients with ARDS (14, 15) . In animals with endotoxin-induced lung injury, elastase activity in the BALF has been reported to increase (16). The administration of neutrophil elastase causes increased vasopermeability, leukocyte accumulation, pulmonary hemorrhage, and parenchymal injury, which are characteristic features of ARDS (6, 17 (data on file; ONO-5046, Ono Pharmaceutical Co., Osaka, Japan). This behavior of the free radical allows for the disordered activation of elastase, leading to tissue injury. ONO-5046 is likely to function effectively in the critical setting where reactive oxygen species coexist, since the drug is still active even in oxidized form (13). Neutrophils adhere to the pulmonary endothelium, consequently injuring them by release of elastase (23). The high-molecular weight inhibitors such as endogenous elastase inhibitors are unable to approach the sites where neutrophils adhere to their targets (7). However, the molecular weight of ONO-5046 is 549, and is so low that the drug probably captures elastase at the aperture between neutrophils and endothelium (7). These characteristics, which are advantages of ONO-5046 over endogenous antiproteases, may justify administration of the exogenous elastase inhibitor.
In the current study, the pulmonary hypertension in the early stage of the acute lung injury was blunted by ONO-5046.
Endotoxin infusion causes aggregation and activation of platelets which release TxA,, resulting in pulmonary hypertension (24, 25) . ONO-5046 attenuated the decrease in peripheral platelet counts. Furthermore, the drug seemed to suppress the increase in TxB, concentration in the BALF, although not significantly.
The drug has no effect on the production of prostanoids in vitro (S. Matsuoka, Ono Pharmaceutical, personal communication). Since neutrophil elastase potentiates catepsin G-induced platelet aggregation (261, the drug may suppress platelet activity, in part, through the inhibition of elastase. The TxB, concentrations in the early periods (1-2 h after endotoxin) remain to be determined.
It is likely that the reduction of the increased PAP by ONO-5046 contributed to the attenuation of the acute lung injury.
A potential negative aspect of ONO-5046-induced impairment of elastase function is a possible increase in susceptibility to infection. The results of the current study do not address this problem, since the effect of ONO-5046 on the bactericidal system was not investigated.
In conclusion, ONO-5046 had a prophylactic effect on endotoxin-induced acute lung injury. Further studies are required to determine whether this drug has a therapeutic effect once the lung injury has developed.
